Vraylar (Allergan USA, Inc.)
Welcome to the PulseAid listing for the Vraylar drug offered from Allergan USA, Inc.. This pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Allergan USA, Inc. |
NON-PROPRIETARY NAME: | cariprazine |
SUBSTANCE NAME: | |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | |
ROUTE: | ORAL |
DOSAGE FORM: | KIT |
MARKETING CATEGORY NAME: | NDA |
START MARKETING DATE: | 2015-09-17 |
END MARKETING DATE: | 0000-00-00 |
Vraylar HUMAN PRESCRIPTION DRUG Details:
Item Description | Vraylar from Allergan USA, Inc. |
LABELER NAME: | Allergan USA, Inc. |
DEA SCHEDULE: | |
ACTIVE STRENGTH: | () |
START MARKETING DATE: | 2015-09-17 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 61874-170_73968081-834a-4d3c-8054-a37179cfe047 |
PRODUCT NDC: | 61874-170 |
APPLICATION NUMBER: | NDA204370 |